Administrating docetaxel, doxorubicin, and cyclophosphamide as a neoadjuvant treatment may decrease lymphedema risk in breast cancer patients
| Image |  |
|---|---|
| Description | scientific article published on 21 February 2018 |
| Author/s |
author: Kadri Altundağ |
| Publication date | February 21, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |